Confidentiality Agreements in the Biotechnology Industry
40 Contracts & Agreements
- Adverum Biotechnologies, Inc. (2 contracts)
- Altimmune, Inc. (1)
- Arbutus Biopharma Corp (21)
- BIOSPECIFICS TECHNOLOGIES CORP (2)
- Cellular Biomedicine Group, Inc. (1)
- CM Life Sciences III Inc. (1)
- GERON CORP (2)
- HEMISPHERX BIOPHARMA INC (1)
- MiMedx Group, Inc. (1)
- PALATIN TECHNOLOGIES INC (1)
- Radius Health, Inc. (1)
- Regeneron Pharmaceuticals (3)
- Sun BioPharma, Inc. (1)
- XBiotech Inc. (1)
- ZAFGEN, INC. (1)
- EQRx, Inc. Form of Employee Confidentiality, Assignment and Non-Solicitation Agreement (CM Life Sciences III Inc., Filed With SEC on August 25, 2021)
- Form of Employee Confidentiality and Intellectual Property Assignment Agreement with Company Officers (Sun BioPharma, Inc., Filed With SEC on August 11, 2020)
- Employment Agreement by and between the Company and Carole Ben-Maimon, M.D., dated July 31, 2020 (including an attached exhibit entitled Confidentiality, Intellectual Property... (ZAFGEN, INC., Filed With SEC on August 6, 2020)
- Confidentiality and Inventions Assignment Agreement, dated April 1, 2020, by and between the Company and Joseph Truitt (BIOSPECIFICS TECHNOLOGIES CORP, Filed With SEC on May 11, 2020)
- April 21, 2020 Mutual Confidentiality Agreement with UMN Pharma Inc., National Institute of Infectious Diseases, and Shionogi & Co., Ltd (HEMISPHERX BIOPHARMA INC, Filed With SEC on April 27, 2020)
- Confidentiality and Inventions Assignment Agreement, dated November 16, 2018, by and between and Dr. Ronald E. Law (BIOSPECIFICS TECHNOLOGIES CORP, Filed With SEC on April 2, 2019)
- Form of Confidentiality and Non-Solicitation Agreement (MiMedx Group, Inc., Filed With SEC on June 12, 2018)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 9, 2016)
- COLLABORATION AGREEMENT by and between REGENERON IRELAND and MITSUBISHI TANABE PHARMA CORPORATION CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR... (Regeneron Pharmaceuticals, Filed With SEC on November 4, 2015)
- IMMUNO-ONCOLOGY LICENSE AND COLLABORATION AGREEMENT By and Between SANOFI BIOTECHNOLOGY SAS and REGENERON PHARMACEUTICALS, INC. Dated as of July 1, 2015 CERTAIN PORTIONS OF THIS... (Regeneron Pharmaceuticals, Filed With SEC on November 4, 2015)
- IMMUNO-ONCOLOGY DISCOVERY AND DEVELOPMENT AGREEMENT By and Between SANOFI BIOTECHNOLOGY SAS and REGENERON PHARMACEUTICALS, INC. Dated as of July 1, 2015 CERTAIN PORTIONS OF THIS... (Regeneron Pharmaceuticals, Filed With SEC on November 4, 2015)
- Confidential treatment has been requestedfor portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions... (Arbutus Biopharma Corp, Filed With SEC on August 7, 2015)
- Confidential treatment has been requested forportions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on August 7, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on May 6, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on May 6, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 13, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 13, 2015)
- SCHEDULE C CONFIDENTIALITY AND ASSIGNMENT OF INVENTIONS AGREEMENT XBIOTECH INC. (XBiotech Inc., Filed With SEC on February 2, 2015)
- EXHIBIT A EMPLOYEE PROPRIETARY INFORMATION AND INVENTIONS ASSIGNMENT AGREEMENT Avalanche Biotechnologies, Inc. EMPLOYEE CONFIDENTIALITY AND INVENTIONS ASSIGNMENT AGREEMENT (Adverum Biotechnologies, Inc., Filed With SEC on December 18, 2014)
- EXHIBIT A EMPLOYEE PROPRIETARY INFORMATION AND INVENTIONS ASSIGNMENT AGREEMENT Avalanche Biotechnologies, Inc. EMPLOYEE CONFIDENTIALITY AND INVENTIONS ASSIGNMENT AGREEMENT (Adverum Biotechnologies, Inc., Filed With SEC on December 18, 2014)
- License, Co-Development and Commercialization Agreement, dated August 29, 2014, by and between Palatin Technologies, Inc. and Chemical Works of Gedeon Richter Plc. We have... (PALATIN TECHNOLOGIES INC, Filed With SEC on September 12, 2014)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on August 14, 2014)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 28, 2014)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 28, 2014)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Arbutus Biopharma Corp, Filed With SEC on March 28, 2014)
- LABORATORY SERVICES AND CONFIDENTIALITY AGREEMENT* (Radius Health, Inc., Filed With SEC on November 9, 2011)
- CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO THE CONFIDENTIALITY REQUEST. OMISSIONS ARE... (GERON CORP, Filed With SEC on February 25, 2011)
- Business Contract/Plan.Please keep it confidential.Author: EastBridge Investment Group Corp Only limited for the internal use of authorized parties: Author (Should the authorized... (Cellular Biomedicine Group, Inc., Filed With SEC on April 15, 2010)
- Form of Confidentiality and Non-SolicitationAgreement (Altimmune, Inc., Filed With SEC on August 14, 2008)
- EXHIBIT 10.1 CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO THE CONFIDENTIALITY REQUEST.... (GERON CORP, Filed With SEC on August 5, 2005)
